SCHEMBL8129222

SCHEMBL8129222

COc1ccc(CNC(SC)=C(C#N)C#N)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
PKM P14618 1/20 0.51
NPC1 O15118 3/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 3/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
EPHX2 P34913 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAOB P27338 2/20 0.44
MAOA P21397 1/20 0.44
ATM Q13315 1/20 0.44
LMNA P02545 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8115432 0.83 ALDH1A1 (0.51) ALDH1A1PKMHPGDKMT2AMEN1
SCHEMBL15649520 0.82 NPC1 (0.50) ALDH1A1PKMNPC1RAB9AHPGD
SCHEMBL8124285 0.82 EPHX2 (0.42) ALDH1A1NPC1KMT2AMEN1EPHX2
SCHEMBL6187669 0.81 IDO1 (0.53) ALDH1A1NPC1RAB9AHPGDKMT2A
SCHEMBL8129896 0.78 ALDH1A1 (0.51) ALDH1A1NPC1RAB9AHPGDKMT2A
SCHEMBL8579767 0.77 NAMPT (0.46) EPHX2L3MBTL1MAPT
SCHEMBL17731575 0.75 ALDH1A1 (0.50) ALDH1A1PKMNPC1RAB9AHPGD
SCHEMBL17731576 0.75 ALDH1A1 (0.50) ALDH1A1PKMNPC1RAB9AHPGD
SCHEMBL22857520 0.73 NPC1 (0.59) ALDH1A1PKMNPC1RAB9AHPGD
SCHEMBL8279987 0.73 ALDH1A1 (0.59) ALDH1A1PKMNPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819129-B1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2000-08-02 EP disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5981533-A INHIBIT THE TYROSINE KINASE ACTIVITY OF THE RECEPTOR FOR EPIDERMAL GROWTH FACTOR AND CAN BE USED IN THE CASE OF EPIDERMAL HYPERPROLIFERATION (PSORIASIS) AND AS ANTI-TUMOR AGENTS NOVARTIS AG (CH) 1999-11-09 US disclosed
WO-1998014449-A1 FUSED PYRAZOLE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-04-09 WO disclosed
EP-0819129-A1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1998-01-21 EP disclosed
WO-1996031510-A1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 1996-10-10 WO disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed